Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Differentiation of c-Kit+ CD24+ natural killer cells into myeloid cells in a GATA-2-dependent manner.

Song B, Lee JM, Park YJ, Kim IK, Kim BS, Shin KS, Jeon I, Koh CH, Bae EA, Seo H, Byun Y, Kang CY.

FASEB J. 2020 Jan 27. doi: 10.1096/fj.201902662R. [Epub ahead of print]

PMID:
31989715
2.

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.

Choi CH, Choi HJ, Lee JW, Kang ES, Cho D, Park BK, Kim YM, Kim DY, Seo H, Park M, Kim W, Choi KY, Oh T, Kang CY, Kim BG.

J Clin Med. 2020 Jan 5;9(1). pii: E147. doi: 10.3390/jcm9010147.

3.

Monocyte-Derived Dendritic Cells Dictate the Memory Differentiation of CD8+ T Cells During Acute Infection.

Shin KS, Jeon I, Kim BS, Kim IK, Park YJ, Koh CH, Song B, Lee JM, Lim J, Bae EA, Seo H, Ban YH, Ha SJ, Kang CY.

Front Immunol. 2019 Aug 16;10:1887. doi: 10.3389/fimmu.2019.01887. eCollection 2019.

4.

Roles of NKT cells in cancer immunotherapy.

Bae EA, Seo H, Kim IK, Jeon I, Kang CY.

Arch Pharm Res. 2019 Jul;42(7):543-548. doi: 10.1007/s12272-019-01139-8. Epub 2019 Mar 11. Review.

PMID:
30859410
5.

GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses.

Kim IK, Koh CH, Jeon I, Shin KS, Kang TS, Bae EA, Seo H, Ko HJ, Kim BS, Chung Y, Kang CY.

Cancer Immunol Res. 2019 Mar;7(3):498-509. doi: 10.1158/2326-6066.CIR-18-0518. Epub 2019 Feb 6.

PMID:
30728152
6.

Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.

Bae EA, Seo H, Kim BS, Choi J, Jeon I, Shin KS, Koh CH, Song B, Kim IK, Min BS, Han YD, Shin SJ, Kang CY.

Cancer Res. 2018 Sep 15;78(18):5315-5326. doi: 10.1158/0008-5472.CAN-18-0734. Epub 2018 Jul 16.

7.

CX3CR1+ Macrophages and CD8+ T Cells Control Intestinal IgA Production.

Kim YI, Song JH, Ko HJ, Kweon MN, Kang CY, Reinecker HC, Chang SY.

J Immunol. 2018 Aug 15;201(4):1287-1294. doi: 10.4049/jimmunol.1701459. Epub 2018 Jul 9.

8.

IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors.

Seo H, Kim BS, Bae EA, Min BS, Han YD, Shin SJ, Kang CY.

Cancer Immunol Res. 2018 Jun;6(6):685-695. doi: 10.1158/2326-6066.CIR-17-0708. Epub 2018 Apr 3.

9.

Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2-positive dendritic cells in allergic asthma.

Cho M, Lee JE, Lim H, Shin HW, Khalmuratova R, Choi G, Kim HS, Choi WS, Park YJ, Shim I, Kim BS, Kang CY, Kim JO, Tanaka S, Kubo M, Tung HY, Landers CT, Corry DB, Kheradmand F, Chung Y.

J Allergy Clin Immunol. 2018 Aug;142(2):530-541.e6. doi: 10.1016/j.jaci.2017.09.019. Epub 2017 Oct 14.

PMID:
29038008
10.

IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours.

Seo H, Jeon I, Kim BS, Park M, Bae EA, Song B, Koh CH, Shin KS, Kim IK, Choi K, Oh T, Min J, Min BS, Han YD, Kang SJ, Shin SJ, Chung Y, Kang CY.

Nat Commun. 2017 Jun 6;8:15776. doi: 10.1038/ncomms15776.

11.

Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice.

Lee SY, Noh Y, Goo JH, Rho S, Kim MJ, Kang CY, Song M, Kim JO.

PLoS One. 2017 Jun 1;12(6):e0176940. doi: 10.1371/journal.pone.0176940. eCollection 2017.

12.

Generation of antigen-specific cytotoxic T lymphocytes with activated B cells.

Yun SO, Shin HY, Kang CY, Kang HJ.

Cytotherapy. 2017 Jan;19(1):119-127. doi: 10.1016/j.jcyt.2016.10.003. Epub 2016 Nov 15.

PMID:
27864016
13.

GITR drives TH9-mediated antitumor immunity.

Kim IK, Chung Y, Kang CY.

Oncoimmunology. 2015 Dec 29;5(5):e1122862. doi: 10.1080/2162402X.2015.1122862. eCollection 2016 May.

14.

Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy.

Bae MJ, See HJ, Choi G, Kang CY, Shon DH, Shin HS.

Mediators Inflamm. 2016;2016:3472608. doi: 10.1155/2016/3472608. Epub 2016 Jun 29.

15.

Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.

Lee KA, Shin KS, Kim GY, Song YC, Bae EA, Kim IK, Koh CH, Kang CY.

Aging Cell. 2016 Apr;15(2):291-300. doi: 10.1111/acel.12435. Epub 2016 Jan 10.

16.

Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.

Kim IK, Kim BS, Koh CH, Seok JW, Park JS, Shin KS, Bae EA, Lee GE, Jeon H, Cho J, Jung Y, Han D, Kwon BS, Lee HY, Chung Y, Kang CY.

Nat Med. 2015 Sep;21(9):1010-7. doi: 10.1038/nm.3922. Epub 2015 Aug 17.

PMID:
26280119
17.

A multimeric carcinoembryonic antigen signal inhibits the activation of human T cells by a SHP-independent mechanism: a potential mechanism for tumor-mediated suppression of T-cell immunity.

Lee KA, Bae EA, Song YC, Kim EK, Lee YS, Kim TG, Kang CY.

Int J Cancer. 2015 Jun 1;136(11):2579-87. doi: 10.1002/ijc.29314. Epub 2014 Nov 21.

18.

Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis.

Kim EK, Jeon I, Seo H, Park YJ, Song B, Lee KA, Jang Y, Chung Y, Kang CY.

Cancer Res. 2014 Nov 15;74(22):6705-16. doi: 10.1158/0008-5472.CAN-14-1482. Epub 2014 Oct 1.

19.

Enhancing T Cell Immune Responses by B Cell-based Therapeutic Vaccine Against Chronic Virus Infection.

Kim MK, Lee A, Hwang YK, Kang CY, Ha SJ.

Immune Netw. 2014 Aug;14(4):207-18. doi: 10.4110/in.2014.14.4.207. Epub 2014 Aug 22.

20.

Design and Evaluation of ω-Hydroxy Fatty Acids Containing α-GalCer Analogues for CD1d-Mediated NKT Cell Activation.

Lim C, Kim JH, Baek DJ, Lee JY, Cho M, Lee YS, Kang CY, Chung DH, Cho WJ, Kim S.

ACS Med Chem Lett. 2014 Feb 4;5(4):331-5. doi: 10.1021/ml400517b. eCollection 2014 Apr 10.

Supplemental Content

Loading ...
Support Center